BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Health Robotics Announces IV Station (TM Pending) a Centrally-Controlled, Modular, Distributed, Flexible, Redundant, Patient-Specific Intra-Venous (IV) Automation Robot

  June 9, 2008

   · 

  3 min read
• Drug Development

  Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease Company to Continue Focus on Pipeline and Haptoglobin Diagnostic Assay

  June 9, 2008

   · 

  6 min read
• Siemens’ New Ultrasound Platform Revolutionizes the Paradigm of Echocardiography

  June 9, 2008

   · 

  4 min read
• Drug Development

  Achillion Pharmaceuticals, Inc. Announces Additional Positive Top-Line Phase 2 Data for Elvucitabine

  June 9, 2008

   · 

  5 min read
• Deals

  PharmaLinkFHI Acquires UK-Based Matrix Contract Research Ltd.

  June 9, 2008

   · 

  1 min read
• Drug Development

  Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue

  June 9, 2008

   · 

  6 min read
• Biotech Bay

  Frost & Sullivan Release: New Product Launches Set to Unleash Multiple Growth Avenues in U.S. Monoclonal Antibodies Market

  June 9, 2008

   · 

  1 min read
• Genetown

  Vertex Pharmaceuticals Incorporated Announces Webcast of its Presentation at the Goldman, Sachs & Co. 29th Annual Global Healthcare Conference

  June 9, 2008

   · 

  1 min read
• Genetown

  ZOLL Medical Corporation to Speak at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference

  June 9, 2008

   · 

  1 min read
• Drug Development

  Cancer and Leukemia Group B Release: Data from Phase II Clinical Trial of Galiximab in Combination with Rituximab in Patients with Previously Untreated Follicular Lymphoma Presented at International Conference on Malignant Lymphoma

  June 9, 2008

   · 

  1 min read